- Home
- MBRX vs ZCMD Comparison
MBRX vs ZCMD Comparison
Compare MBRX & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBRX | ZCMD |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | China |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 6.1M |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MBRX | ZCMD |
|---|---|---|
| Price | $2.01 | $1.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $105.50 | N/A |
| AVG Volume (30 Days) | ★ 239.2K | 181.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $0.18 |
| 52 Week High | $7.98 | $1.93 |
Technical Indicators
Market Signals| Indicator | MBRX | ZCMD |
|---|---|---|
| Relative Strength Index (RSI) | 29.17 | 83.26 |
| Support Level | $0.37 | $1.02 |
| Resistance Level | $5.22 | $1.93 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | -0.05 | 0.14 |
| Stochastic Oscillator | 24.83 | 98.57 |
Price Performance
Historical ComparisonAbout MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.